Cigna to Cover GenomeDx's Decipher Prostate Cancer Tests

Dec

Application of a Novel ISH Approach to Elucidate Splice Variants in Schizophrenia

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.

Dec

Featured Webinar

Clinical-Grade Exome Analysis for Complex and Unsolved Case Investigations

This webinar will discuss the use of clinical-grade exome analysis application in complex case investigations.

Dec

Featured Webinar

Precision Metagenomics to Identify Patients at Risk for Invasive Infection

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.

Main menu

Cigna to Cover GenomeDx's Decipher Prostate Cancer Tests

To read the full story....

Breaking News

CareDx Prices $49M Common Stock Offering

OpGen Posts 26 Percent Revenue Decline in Q3

Interpace Diagnostics Q3 Revenues Up 38 Percent

OncoCyte Q3 Net Loss Narrows

UPDATE: Biocept Q3 Revenues Drop 31 Percent as Test Volume Shrinks

Health Canada Approves Two BCR-ABL Tests

Featured White Papers

Application of a Novel ISH Approach to Elucidate Splice Variants in Schizophrenia

Clinical-Grade Exome Analysis for Complex and Unsolved Case Investigations

Precision Metagenomics to Identify Patients at Risk for Invasive Infection

What's Popular?

Point-of-Care Molecular Diagnostic Platform That Skips Need for Amplification Being Developed at UCLA

BioMérieux Pneumonia Panels Get FDA 510(k) Clearance, CE Mark

CareDx Prices $49M Common Stock Offering

Natera Waits for ACOG Guidance on Average-Risk NIPT; Pushes Ahead in Oncology, Transplantation

Health Canada Approves Two BCR-ABL Tests

Sponsorships